📰 Kenneth Marek News
Kenneth Marek News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kenneth Marek. Real-time updates on events, politics, business and more.
May 23, 2023
The absence of any biomarker capable of detecting Parkinson's in the earliest stages has hindered finding new treatments. This may be about to change.
April 17, 2023
The Michael J. Fox Foundation for Parkinson's Research (MJFF), confirms the most significant breakthrough yet in the search for a Parkinson's biomarker: a biological test for Parkinson's disease that demonstrates high diagnostic accuracy, differentiates molecular subtypes and detects disease in individuals before cardinal movement symptoms arise. The new test, known as the alpha-synuclein seed amplification assay (?Syn-SAA), heralds the revolutionary ability for research to define Pa...
April 14, 2023
A study sponsored by The Michael J. Fox Foundation finds a test of spinal fluid may be able to predict who is likely to develop Parkinson’s disease.
April 12, 2023
New paper in The Lancet Neurology confirms that a key Parkinsons pathology can now be identified by examining spinal fluid from living patients Test validated...
April 12, 2023
New paper in The Lancet Neurology confirms that a key Parkinson's pathology can now be identified by examining spinal fluid from living patientsTest validated in the gold-standard Parkinson's
April 12, 2023
New paper in The Lancet Neurology confirms that a key Parkinsons pathology can now be identified by examining spinal fluid from living patients Test validated...
December 15, 2022
/PRNewswire/ -- XINGIMAGING, LLC, and MITRO Biotech Co., Ltd. each highly recognized for drug development and imaging solutions, announce today that they will...
December 15, 2022
NEW HAVEN, Conn., Dec. 15, 2022 /PRNewswire/ -- XINGIMAGING, LLC, and MITRO Biotech Co., Ltd. each highly recognized for drug development and imaging solutions, announce today that they will
February 25, 2021
Abstract The Aligning Science Across Parkinson’s (ASAP) initiative was set up to improve understanding of the biology underlying the onset and progression of Parkinson’s disease. With an emphasis on open science and collaboration, we have assembled a research network led by nearly 100 investigators to explore the pathology of Parkinson’s disease, and this network will soon expand to include researchers working on relevant (dys)-functional neural circuits. We have also contributed to large...